Gastroprotective and anti-Helicobacter pylori potential of herbal formula HZJW: Safety and efficacy assessment

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Xie, Jian Hui ^a   Chen, Yun Long ^a   Wu, Qing He ^a   Wu, Jun ^b   Su, Ji Yan ^a   Cao, Hong Yin ^a   Li, Yu Cui ^a   Li, Yi Sheng ^c   Liao, Jin Bin ^a   Lai, Xiao Ping ^a   Huang, Ping ^a   Su, Zi Ren ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b Shandong College of Traditional Chinese Medicine   (China)

^c Shenzhen ENT Institute   (China)

Author keywords

Cytoprotective; Gastroduodenal ulcer; Helicobacter pylori; HZJW; Safety; TCM

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; AMOXICILLIN; ANTIINFECTIVE AGENT; CHLORIDE; HZJW EXTRACT; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; RANITIDINE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOOD INTAKE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMATOLOGY; HERBAL MEDICINE; HISTOPATHOLOGY; IN VITRO STUDY; MALE; MORTALITY; NONHUMAN; OPHTHALMOLOGY; STOMACH ULCER;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICE; MICE, INBRED BALB C; PEPTIC ULCER; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84878227221     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-119     Document Type: Article

References (45)

1. Rao CV, Saíram K, Goel RK. Experimental evaluation of Bacopamonniera on rat gastric ulceration and secretion. Indian J Physiol Pharmacol 2000, 44:335-441.
2. Soll AH. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. J Am Med Assoc 1996, 275:622-629.
3. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988, 2:1437-1442.
4. Bighetti AE, Antonio MA, Kohn LK, Rehder VL, Foglio MA, Possenti A, Vilela L, Carvalho JE. Antiulcerogenic activity of a crude hydroalcoholic extract and coumarin isolated from Mikania laevigata Schultz Bip. Phytomedicine 2005, 12:72-77. 10.1016/j.phymed.2003.09.006, 15693711.
5. Ramakrishnan K, Salinas RC. Peptic ulcer disease. Am Fam Physician 2007, 76:1005-1012.
6. Hoffelner H, Rieder G, Haas R. Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model. Int J Med Microbiol 2008, 298:151-159. 10.1016/j.ijmm.2007.07.006, 17714988.
7. Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter 2007, 12:89-102. 10.1111/j.1523-5378.2007.00478.x, 17309745.
8. Borrelli F, Izzo AA. The plant kingdom as a source of antiulcer remedies. Phytother Res 2000, 14:581-591. 10.1002/1099-1573(200012)14:8<581::AID-PTR776>3.0.CO;2-S, 11113992.
9. Ananya C, Sirshendu C, Sandip KB. H. pylori-induced Gastric Ulcer: Pathophysiology and Herbal Remedy. Int J Biol Med Res 2012, 3:1461-1465.
10. Xing HL. Observation of clinical efficacy of Huang-zhu-jian-wei Fang (HZJW) on 89 cases of chronic superficial gastritis disease. Acta Chin Med Pharmacol 2011, 39:125-126.
11. Chen JP, Li YS, Yu XF, Chen YL, Lin RF, He YH, Lin J, Su ZR. RP-HPLC simultaneous determi nation of three kinds of components in Huangzhu Jianwei tablets. Chin J Pharm Anal 2010, 30(11):2157-2159.
12. Li Y, Xu C, Zhang Q, Liu JY, Tan RX. In vitro anti- Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases. J Ethnopharmacol 2005, 98:329-333. 10.1016/j.jep.2005.01.020, 15814268.
13. Lee HB, Lee HK, Kim JR, Ahn YJ. Anti-Helicobacter pylori Diarylheptanoid Identified in the Rhizome of Alpinia officinarum. J Korean Soc Appl Bi 2009, 52:367-370.
14. Lu JS, Liu YQ, Li M, Li BS, Xu Y. Protective effects and its mechanisms of total alkaloids from Rhizoma Coptis Chinensis on Helicobacter pylori LPS induced gastric lesion in rats. China J Chin Mater Med 2007, 32:1333-1336.
15. Han YH, Lee KD, Lee DU. Anti-Helicobacter pylori Activity and Structure-Activity Relationships of Berberine Derivatives. B Korean Chem Soc 2009, 30:3147-3149.
16. Mahady GB, Pendland SL, Stoia A, Chadwick LR. In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis Canadensis. Phytother Res 2003, 17:217-221. 10.1002/ptr.1108, 12672149.
17. China Pharmacopoeia Committee Pharmacopoeia of the People's Republic of China (I) 2010, Beijing: Chemical Industry Press, Pharmacopoeia of the People's Republic of China (IV), China Pharmacopoeia Committee.
18. Morimoto Y, Shimohara K, Oshima S, Sukamoro T. Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of terprenone and cimetidina. Jpn J Pharmacol 1991, 57:955-6053.
19. Nwafor PA, Okwuasaba FK, Binda LG. Antidiarrhoel and antiulcerogenic effects of methanolic extract of Asparagus pubescens root in rats. J Ethnopharmacol 2000, 72:421-427. 10.1016/S0378-8741(00)00261-0, 10996281.
20. Boda M, Tan PV, Nyasse B. Rapid in vivo screening method for the evaluation of new anti-Helicobacter medicinal plant preparations. Afri J Tradit Complem 2006, 3:102-114.
21. The Organization of Economic Co-operation and Development (OECD) The OECD guideline for testing of chemicals: 420 Acute oral toxicity 2001, Paris: OECD, The Organization of Economic Co-operation and Development (OECD).
22. Rosidah X, Yam MF, Sadikun A, Ahmad M, Akowuah GA, Asmawi MZ. Toxicology evaluation of standardized methanol extract of Gynura procumbens. J Ethnopharmacol 2009, 123:244-249. 10.1016/j.jep.2009.03.011, 19429368.
23. Seeff LB. Herbal hepatotoxicity. Clin Liver Dis 2007, 11:577-596. 10.1016/j.cld.2007.06.005, 17723921.
24. Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet 2008, 372:1938-1940. 10.1016/S0140-6736(08)61354-9, 18930523.
25. Veiga-Junior VF, Pinto AC, Maciel MAM. Medicinal plants: safe cure?. Quim Nova 2005, 28:519-528.
26. Saad B, Azaizeh H, Abu-Hijleh G, Said O. Safety of traditional Arab herbal medicine. Evid-based Compl Alt 2006, 3:433-439.
27. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephro-pathy: a worldwide problem. Kidney Int 2008, 74:158-169. 10.1038/ki.2008.129, 18418355.
28. Castro1 LS, Perazzo FF, Maistro EL. Genotoxicity testing of Ambelania occidentalis (Apocynaceae) leaf extract in vivo. Genet Mol Res 2009, 8(2):440-447. 10.4238/vol8-2gmr588, 19551631.
29. Tan PV, Dimo T, Dongo E. Effects of methanol, cyclohexane and methylene chloride extracts of Bidens pilosa on various gastric ulcer models in rats. J Ethnopharmacol 2000, 73:415-421. 10.1016/S0378-8741(00)00290-7, 11090994.
30. Klein-Junior LC, Santin JR, Niero R, DE Andrade SF, Cechinel-Filho V. The therapeutic lead potential of metabolites obtained from natural sources for the treatment of peptic ulcer. Phytochem Rev 11:567-616.
31. Nasuti C, Gabbianelli R, Falcioni G, Cantalamessa F. Antioxidative and gastroprotective activities of anti-inflammatory formulations derived from chestnut honey in rats. Nutr Res 2006, 26:130-137.
32. Sumitra C, Yogesh B, Mital K. Protective effect of Polyalthia longifolia var. pendula leaves on ethanol and ethanol/HCl induced ulcer in rats and its antimicrobial potency. Asian Pac J Trop Med 2011, 673-679.
33. Moleiro FC, Andreo MA, De Santos RC, Moraes TDM, Rodrigues CM, Carli CB, Lopes FC, Pellizzon CH, Carlos IZ, Bauab TM, Vilegas W, Hiruma-Lima CA. Mouriri elliptica: Validation of gastroprotective, healing and anti-Helicobacter pylori effects. J Ethnopharmaco 2009, 123:359-368.
34. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?. Physiol Rev 2008, 88:1547-1565. 10.1152/physrev.00004.2008, 18923189.
35. Malfertheiner P, Chan FKL, McColl KEL. Peptic ulcer disease. Lancet 2009, 374:1449-1461. 10.1016/S0140-6736(09)60938-7, 19683340.
36. Wallace JL. Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Best Pract Res Cl Ga 2001, 15:691-703.
37. Shi R, Xu S, Zhang H, Ding Y, Sun G, Huang X, Chen X, Li X, Yan Z, Zhang G. Prevalence and risk factors for Helicobacter pylori infection in Chinese Populations. Helicobacter 2008, 13:157-165. 10.1111/j.1523-5378.2008.00586.x, 18321305.
38. Ge Z, Taylor DE. Contribution of genome sequencing to understanding the biology of Helicobactor pylori. Annual Rev Microbiol 1999, 53:358-387.
39. Cave DR. Transmission and epidemiology of Helicobactor pylori. Am J Med 1996, 100:12-17. 10.1016/S0002-9343(96)90004-2, 8579078.
40. Vandana B, Vidya S. Rapid Urease Test to Diagnose Helicobacter Pylori Infection. JK Sci 2006, 8:86-88.
41. Adamek RJ, Wegener M, Opferkuch W, Ruhl GH. Successful Helicobacter pylori eradication: a systemic effect of antibiotics?. Am J Gastroenterol 1993, 88:792-793.
42. Goddard AF, Jessa MJ, Barrett DA, Shaw PN, Idstrom JP, Cederberg C. Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. Gastroenterol 1996, 111:358-367.
43. Loomis TA, Hayes AW. Essentials of Toxicology 1996, London: Academic Press Limited, 4.
44. Greaves P. 2007, Amsterdam: Elsevier Academic Press, 3, Histopathology of Preclinical Toxicity Studies.
45. Derelanko MJ. The Toxicologist's Pocket Handbook 2008, UK: Informa Healthcare, 2.